| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2217/FCA.10.191 |
| P698 | PubMed publication ID | 21453026 |
| P50 | author | Olivia Wu | Q47436325 |
| P2093 | author name string | Peter Clark | |
| P2860 | cites work | ABO blood groups in relation to ischaemic heart disease | Q49716991 |
| The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. | Q51036744 | ||
| Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. | Q51773327 | ||
| Activated protein C resistance: the influence of ABO-blood group, gender and age. | Q53850991 | ||
| Letter: Maternal blood group A and pre-eclampsia. | Q55352407 | ||
| ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study | Q57300709 | ||
| Risk of acute ischemic heart disease in postmenopausal women depends on von Willebrand factor and fibrinogen concentrations, and blood group genotype | Q57910201 | ||
| A genome-wide association study identifies protein quantitative trait loci (pQTLs) | Q21145048 | ||
| Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study | Q28196342 | ||
| ABO genotype and risk of thrombotic events and hemorrhagic stroke | Q30496759 | ||
| Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women | Q33349442 | ||
| ABO blood groups and genetic risk factors for thrombosis in Croatian population | Q33573170 | ||
| The epidemiology of venous thromboembolism in the community | Q33865646 | ||
| Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels | Q34113248 | ||
| Risk factors for venous thrombosis - current understanding from an epidemiological point of view. | Q34114450 | ||
| ABO blood group genotype and plasma von Willebrand factor in normal individuals. | Q34304017 | ||
| Mutation in blood coagulation factor V associated with resistance to activated protein C. | Q34340007 | ||
| Thrombophilia, clinical factors, and recurrent venous thrombotic events | Q34419598 | ||
| The phenomenon known as acquired activated protein C resistance | Q34530144 | ||
| ABO blood group and ischaemic heart disease in British men | Q35169778 | ||
| Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization | Q36212119 | ||
| ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? | Q36604393 | ||
| ABO blood groups and ischaemic heart disease in men | Q36925068 | ||
| ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. | Q36987171 | ||
| Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups | Q39367489 | ||
| AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms | Q40106654 | ||
| Investigation of associations between ABO blood groups and coagulation, fibrinolysis, total lipids, cholesterol, and triglycerides | Q41684229 | ||
| Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population | Q42224125 | ||
| A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor | Q42524319 | ||
| Intraplatelet von willebrand factor and ABO blood group | Q43410673 | ||
| Venous thromboembolic disease and ABO blood type. A cooperative study | Q43519021 | ||
| Blood Groups, Myocardial Infarction and Angina Pectoris among 10,000 Adult Males | Q44056121 | ||
| An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. | Q44518932 | ||
| Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process? | Q44545077 | ||
| Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals | Q45192189 | ||
| ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). | Q45217593 | ||
| Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo. | Q45261110 | ||
| Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study | Q46334817 | ||
| Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis | Q46484313 | ||
| Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight | Q47272009 | ||
| Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication | Q47762914 | ||
| P433 | issue | 2 | |
| P921 | main subject | thrombosis | Q261327 |
| P304 | page(s) | 191-201 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Future Cardiology | Q15765184 |
| P1476 | title | ABO blood groups and thrombosis: a causal association, but is there value in screening? | |
| P478 | volume | 7 |
| Q33735247 | ABO blood groups and risk of deep venous thromboembolism in Chinese Han population from Chaoshan region in South China |
| Q33645908 | Blood groups and acute aortic dissection type III |
| Q43066477 | Evaluation of ABO blood groups as a risk factor for myocardial infarction. |
| Q34607044 | Risk factors for thrombosis in an african population. |
| Q40037618 | The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection |
| Q50525716 | The influence of maternal Lewis, Secretor and ABO(H) blood groups on fetal growth restriction. |
| Q47561659 | The relationship between immunogenic red blood cell antigens and Human Immunodeficiency Virus infection |
| Q40795743 | The role of red blood cells in enhancing or preventing HIV infection and other diseases |
Search more.